Can NIB shares reach $9 by Christmas?

It has been a good few weeks for shareholders. Can the stock keep going?

| More on:
ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance,

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The NIB Holdings Limited (ASX: NHF) share price has risen 8% since 8 November 2023 to reach $7.70. Is it possible the NIB share price could go up another 17% to $9 by Christmas?

The ASX healthcare share mainly offers exposure to private health insurance for Australian residents, but it also offers things like non-Australian private health insurance, travel insurance and has growing exposure to the NDIS.

Christmas is only 20 days away, which is a very short timeframe in investment terms. I believe investors should focus on long-term investing, but it's good to consider the outlook for NIB shares.

Expert view on the NIB share price

NIB recently released its AGM trading update for the first few months of FY24, which showed "overall volume and topline momentum is generally upbeat" in UBS' words.

Since June 2023, the Australian resident health insurance division has seen policy numbers rise by 1.3%, implying growth is "tracking towards the top end of the FY24 guidance range of 3% to 4%." Premium growth of 10.5% is tracking ahead of UBS' estimate.

In the international health insurance division, policy numbers have "maintained strong momentum", with 5.2% growth since June 2023, ahead of UBS' forecasts. UBS said premium growth ahead of policy growth indicates repricing support – the broker thinks there is further margin expansion ahead.

In New Zealand, growth is tracking at the low end, while travel policy numbers and premiums were both down in the double-digits because of the end of the Qantas Airways Limited (ASX: QAN) distribution arrangement in July. The Woolworths Group Ltd (ASX: WOW) contract will start contributing in the second half of FY24.

UBS also pointed to claims indicators suggesting that "claims inflation remains under control". Though the company did not detail claims costs in the first quarter of FY24, there are "potential efficiency gains". The broker also suggested recent Medicare monthly data has "generally been supportive."

Forecasts for the ASX healthcare share

The broker has forecast that NIB could generate earnings per share (EPS) of 48 cents and pay an annual dividend per share of 34 cents. That would put the current NIB share price at 16 times FY24's estimated earnings with a grossed-up dividend yield of 6.3%.

The broker rating on NIB shares is a buy, with a price target of $9.50. A price target is for 12 months, not for Christmas, but it does suggest that NIB shares could rise 24% over the next year if UBS ends up being correct.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended NIB Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Two happy scientists analysing test results in a lab
Share Market News

Here's how the ASX 200 market sectors stacked up last week

ASX healthcare shares were strongest among the 11 market sectors last week.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Healthcare Shares

ResMed share price jumps 10% on strong quarterly update

ResMed has impressed the market with its third-quarter update.

Read more »

Happy healthcare workers in a labs
Healthcare Shares

Up 74% in 6 months, guess which ASX 200 healthcare stock just hit another all-time high

This company has busily deployed cash over the past six months while growing at a phenomenal pace.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Broker says this ASX biotech stock could almost double in value

Bell Potter is feeling very bullish about this risky stock.

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Woman going for a scan reassured by doctor
Healthcare Shares

How AI could boost this ASX 300 healthcare stock

The Firetrail investment management team see AI providing a 'material tailwind' for this stock.

Read more »

A man in a white coat holds a laptop in one hand and his head in the other, it's bad news.
Healthcare Shares

Why is the ResMed share price diving 5% today?

Weight loss wonder drugs are weighing heavily on this stock.

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

Why is the Telix share price jumping 15% to a record high?

This healthcare stock is scaling new heights on Thursday. But why?

Read more »